264 related articles for article (PubMed ID: 16575786)
1. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells.
Schneider-Stock R; Kuester D; Ullrich O; Mittag F; Habold C; Boltze C; Peters B; Krueger S; Hintze C; Meyer F; Hartig R; Roessner A
J Pathol; 2006 May; 209(1):95-105. PubMed ID: 16575786
[TBL] [Abstract][Full Text] [Related]
2. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion.
Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2002 Feb; 21(8):1217-24. PubMed ID: 11850841
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer.
Chan AW; Chan MW; Lee TL; Ng EK; Leung WK; Lau JY; Tong JH; Chan FK; To KF
Oncol Rep; 2005 May; 13(5):937-41. PubMed ID: 15809761
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923
[TBL] [Abstract][Full Text] [Related]
7. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
Wethkamp N; Ramp U; Geddert H; Schulz WA; Florl AR; Suschek CV; Hassan M; Gabbert HE; Mahotka C
Eur J Cancer; 2006 Jan; 42(2):264-74. PubMed ID: 16386893
[TBL] [Abstract][Full Text] [Related]
8. Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma.
Ng MH; To KW; Lo KW; Chan S; Tsang KS; Cheng SH; Ng HK
Clin Cancer Res; 2001 Jun; 7(6):1724-9. PubMed ID: 11410512
[TBL] [Abstract][Full Text] [Related]
9. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
Nakatsuka S; Takakuwa T; Aozasa K
Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract][Full Text] [Related]
13. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer.
Cohen O; Kimchi A
Cell Death Differ; 2001 Jan; 8(1):6-15. PubMed ID: 11313698
[TBL] [Abstract][Full Text] [Related]
14. Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Amiñoso C; De Campos JM; Isla A; Gutierrez M; Rey JA
Oncol Rep; 2003; 10(4):1031-3. PubMed ID: 12792765
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer.
Sobti RC; MalekZadeh K; Nikbakht M; Sadeghi IA; Shekari M; Singh SK
Biomarkers; 2010 Mar; 15(2):167-74. PubMed ID: 19958159
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
[TBL] [Abstract][Full Text] [Related]
19. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.
Tada Y; Wada M; Taguchi K; Mochida Y; Kinugawa N; Tsuneyoshi M; Naito S; Kuwano M
Cancer Res; 2002 Jul; 62(14):4048-53. PubMed ID: 12124340
[TBL] [Abstract][Full Text] [Related]
20. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]